Inventurus Knowledge Solutions Limited, operating as IKS Health, delivered $12 million in annual cash impact for Axia Women's Health, a leading U.S. women's healthcare provider. The partnership scaled to include 100% of coding volume, up from 60%, resulting in measurable improvements in coding accuracy, charge capture, and overall revenue cycle management performance.

The financial and operational improvements included a 36% reduction in total denial rate to 5.5% and a 37% reduction in total coding-specific denials to 2.4%. Coding accuracy exceeded 96%, while charges and CPTs per visit increased by 10% due to the identification of potentially missed billable services. Monthly collections rose by $1.6 million to $14.3 million, and the accounts receivable status improved by 1.3 days to 38.7 days.

Performance Metrics

As Axia Women's Health scaled its multi-site network, IKS Health increased coding volume to cover all sites. This shift allowed clinicians and care teams to dedicate more time to patient care and less time on administrative tasks while maintaining consistent, high-quality care.

IKS Health coders functioned as an extension of Axia's clinical and billing teams, validating clinician-entered CPT codes against supporting documentation. Regular chart reviews identified opportunities to strengthen accuracy and support appropriate reimbursement, including aligning evaluation and management levels with documentation and coding potentially missed billable services.

Inventurus Knowledge Solutions has approved an additional investment of up to USD 15,000,000 in its associate company, IKS WWMG MSO LLC, to increase its stake from 48.02% to 63.49%. The investment will be made by Inventurus Knowledge Solutions Inc, a wholly-owned subsidiary, through the subscription of up to 15,000,000 Common Units at USD 1 per Unit. The transaction is expected to be completed on or before March 31, 2029, with the first tranche of USD 3,000,000 scheduled for investment on or before July 3, 2026. The total investment by the company stands at USD 17 million and is expected to reach USD 32 million by 2029.

The Board of Directors approved the investment at its meeting held on June 29, 2026. The disclosure was made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company stated that the transaction is between two related parties, but the promoter group does not hold any interest in the target entity.

Strategic Rationale and Implementation

The group intends to use the investment to strategically elevate its market position from a service provider to a transformation partner. The objective is to create a sustainable physician aggregation model and enhance the stickiness of its care enablement platform. The capital allocation targets strategic growth initiatives, including physician hiring, Value-Based Care (VBC) expansion, and general working capital support. Currently, 13 recently acquired physicians are in their initial ramp-up stage, with recruitment for an additional nine doctors slated for the coming 6 months.

Platform adoption is nearly complete following the resolution of initial Epic access challenges. As of June 2026, 95% clinicians have been successfully onboarded onto the Scribble platform. Key technologies such as the Virtual Clinic Assistant, Referral Management, and My Care Hub are operational. Ongoing technical specification updates are in progress to resolve remaining data compatibility issues for EVE - Prior Authorization. The organization anticipates growth as these clinical practices reach maturity, leading to increased operating leverage and a projected rise in IKS platform services revenue.

Operational Performance

The investment is progressing as expected, with visible improvements in operational efficiency. Revenue Cycle Management (RCM) optimization has successfully reduced Days Sales Outstanding (DSO) from 46.1 days to 41.7 days. Visit counts increased by 3% from April to May 2026 as platform implementation accelerated. Additionally, all VBC agreements have been renegotiated to contribute to future revenue growth. The organization has taken actions that will result in USD 2.5 million of annualised savings in the upcoming year. WWMG continues to be a top 10 customer for IKS.

Financial Details of Target Entity

IKS WWMG MSO LLC was incorporated on June 12, 2025, in the United States. The entity provides management, consulting, administrative, and other support services to physician practices. The investment will be funded through cash consideration, and the transaction does not require any specific governmental or regulatory approvals. The financial details for FY 2025-26 are as follows:

WWMG serves as a brand ambassador and reference site, enhancing market credibility. Its endorsement facilitated securing full platform deals with similar physician-led multi-speciality groups and enabled the organization to obtain a license as an Accountable Care Organization (ACO) convenor.